Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (2.068)

1

Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer : An Australian case series

enthalten in: Asia-Pacific journal of clinical oncology | 2019

von Bergin, A. | Luen, S. | Savas, P. | +8

2

fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification

enthalten in: International journal of cancer | 2019

von Takegawa, N. | Tsurutani, J. | Kawakami, H. | +8

3

The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer : a rapid review

enthalten in: Systematic reviews | 2019

von Van den Nest, M. | Glechner, A. | Gold, M. | +1

4

Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer : Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)

enthalten in: European journal of medicinal chemistry | 2019

von Xu, Z. | Guo, D. | Jiang, Z. | +8

5

The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer

enthalten in: The breast journal | 2019

von Dreyfuss, A. | Barsky, A. | Taunk, N. | +2

6

Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2019

von Pereira, P. | Mandleywala, K. | Ragupathi, A. | +4

7

Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients

enthalten in: Biomolecules | 2019

von Koh, J. | Nam, S. | Lee, Y. | +10

8

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines

enthalten in: BMC health services research | 2019

von Genuino, A. | Chaikledkaew, U. | Guerrero, A. | +2

9

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer : Final results from MARIANNE

enthalten in: Cancer | 2019

von Perez, E. | Barrios, C. | Eiermann, W. | +12

10

Systemic treatment of patients with early breast cancer : recent updates and state of the art

enthalten in: Breast (Edinburgh, Scotland) | 2019

von Caparica, R. | Brandão, M. | Piccart, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[207]